Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UGT2B17 |
| Upstream (Parents) |
|---|
| (<<) UGT2B15 → UGT2B17 |
| (<<) UGT1A9///UGT1A6///UGT1A8 → UGT2B17 |
| (<<) A1CF → UGT2B17 |
| (<<) CYP4F3 → UGT2B17 |
| (<<) MGMT → UGT2B17 |
| (<<) PBLD → UGT2B17 |
| (<<) ECHDC2 → UGT2B17 |
| Downstream (Children) |
|---|
| UGT2B17 → CELA3B (>>) |
| UGT2B17 → CACNG5 (>>) |
| UGT2B17 → AAK1 (>>) |
| UGT2B17 → DUSP21 (>>) |
